Table 5.
Adverse cardiovascular events in COVID-19 patients with cancer.
| CV Event |
No CVD/CVRF |
CVRF |
Established CVD |
P-valuea | |||
|---|---|---|---|---|---|---|---|
| N | n (%) | N | n (%) | N | n (%) | ||
| VTE | 4593 | 186 (4) | 4017 | 214 (5) | 2170 | 101(5) | 0.0194 |
| MI | 4593 | 18 (0) | 4017 | 59 (1) | 2169 | 69 (3) | <0.001 |
| AF | 4593 | 67 (1) | 4027 | 240 (6) | 2171 | 223 (10) | <0.001 |
| VF | 4593 | 2* (0) | 4016 | 13 (0) | 2168 | 14 (1) | <0.001 |
| CMP | 4593 | 5* (0) | 4017 | 25 (1) | 2168 | 32 (1) | <0.001 |
| HF | 4593 | 27 (1) | 4016 | 78 (2) | 2172 | 188 (9) | <0.001 |
| CVA | 4593 | 22 (0) | 4017 | 35 (1) | 2168 | 43 (2) | <0.001 |
| Hypotension | 4597 | 341 (7) | 4029 | 509 (13) | 2173 | 356 (16) | <0.001 |
a
Fisher's exact test.
⁎
Cells with counts 1–4 are masked to minimize the risk of re-identification.
Abbreviations: AF = atrial fibrillation, CMP = cardiomyopathy, CVD = cardiovascular disease, CVRF = cardiovascular risk factors, HF = symptomatic heart failure, VF = ventricular fibrillation, VTE = venous thromboembolism.